Affiliation:
1. Peking University First Hospital
Abstract
Abstract
Objectives: To systematically evaluate the efficacy of low molecular weight heparin (LMWH) to prevent preeclampsia in high risk pregnant women without thrombophilia.
Search strategy: PubMed, Embase and the Cochrane library were searched for articles published before 1st August 2022 using the combination keywords “preeclampsia”, “Low Molecular Weight Heparin”, “LMWH”, “Heparin, Low Molecular Weight”, “Dalteparin”, “Nadroparin”, and “Tinzaparin”. Selection criteria: Randomized controlled trials evaluating the use of LMWH in pregnant women at high risk of preeclampsia without thrombophilia.
Data collection and analysis: Ten studies were included in the meta-analysis (1758 patients in total). Outcomes were expressed as relative risk (RR) with 95% confidence intervals (CI).
Results: LMWH reduced the incidence of PE (RR=0.67; 95% CI=0.50-0.90; P=0.009) in high risk pregnant women without thrombophilia. Subgroup analysis found that the prophylactic effect of LMWH was only significant in studies using low-dose aspirin (LDA) as the primary intervention. LMWH was also effective for the prevention of preterm birth and fetal growth restriction, but had no effect on the incidence of placenta abruption.
Conclusion: For women at high risk of developing preeclampsia without thrombophilia, the combination of LMWH and low‐dose aspirin is effective for the prevention of preeclampsia, preterm birth and fetal growth restriction and is superior to LDA alone.
Publisher
Research Square Platform LLC
Reference22 articles.
1. Tranquilli AL, Dekker G, Magee L et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP.Pregnancy Hypertens2014; 4(2).
2. Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia.Lancet2016; 387(10022).
3. Research Recommendations From the National Institutes of Health Workshop on Predicting, Preventing, and Treating Preeclampsia;Maric-Bilkan C;Hypertension,2019
4. Pre-eclampsia part 2: prediction, prevention and management;Chaiworapongsa T;Nat Rev Nephrol,2014
5. The Safety of Low-Molecular-Weight Heparin During and After Pregnancy;Lu E;Obstet Gynecol Surv,2017